These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3518296)

  • 1. Intraphagocytic bactericidal activity of ofloxacin compared with that of aztreonam and ceftriaxone against Serratia marcescens.
    Traub WH; Spohr M; Bauer D
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Feb; 261(1):85-94. PubMed ID: 3518296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraphagocytic bactericidal activity of bacterial DNA gyrase inhibitors against Serratia marcescens.
    Traub WH
    Chemotherapy; 1984; 30(6):379-86. PubMed ID: 6097410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of antimicrobial drugs and combined phagocytic/serum bactericidal activity of defibrinated human blood against Serratia marcescens. III. beta-Lactam antibiotics and fosfomycin.
    Traub WH
    Chemotherapy; 1983; 29(1):48-57. PubMed ID: 6339180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined serum bactericidal and phagocytic activities of defibrinated human blood against Serratia marcescens. Use of phenylbutazone to selectively block phagocytic killing activity and of Group A (phage tail) bacteriocins to kill extraphagocytic bacteria.
    Traub WH
    Chemotherapy; 1982; 28(5):355-62. PubMed ID: 6754279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of antimicrobial drugs and combined phagocytic/serum bactericidal activity of defibrinated human blood against Serratia marcescens. I. Cotrimoxazole, nalidixic acid, nitrofurantoin, and trimethoprim.
    Traub WH
    Chemotherapy; 1982; 28(5):369-80. PubMed ID: 6754280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of antimicrobial drugs and combined phagocytic/serum bactericidal activity of defibrinated human blood against Serratia marcescens. II. Aminoglycosides: amikacin, gentamicin, and netilmicin.
    Traub WH
    Chemotherapy; 1982; 28(6):434-43. PubMed ID: 6761079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of antimicrobial drugs and combined phagocytic/serum bactericidal activity of defibrinated human blood against Serratia marcescens. IV. N-formimidoyl thienamycin.
    Traub WH
    Chemotherapy; 1983; 29(2):121-7. PubMed ID: 6340990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudomonas aeruginosa: in vitro susceptibility to antimicrobial drugs, single and combined, with and without defibrinated human blood.
    Traub WH; Spohr M; Bauer D
    Chemotherapy; 1988; 34(4):284-97. PubMed ID: 3145172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of polymyxin B nonapeptide to augment bactericidal activities of novobiocin, rifampin, and of defibrinated human blood against Serratia marcescens.
    Traub WH; Kohl KH; Spohr M; Bauer D
    Chemotherapy; 1988; 34(3):195-201. PubMed ID: 2843325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum bactericidal activity of aztreonam, cefoperazone, and amikacin, alone or in combination, against Escherichia coli, Klebsiella pneumoniae, Serratia marcescens, and Pseudomonas aeruginosa.
    Van Laethem Y; Husson M; Klastersky J
    Antimicrob Agents Chemother; 1984 Aug; 26(2):224-7. PubMed ID: 6435515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth curve patterns of Escherichia coli, Serratia marcescens, and Proteus vulgaris submitted to different tigemonam concentrations.
    Yourassowsky E; van der Linden MP; Lismont MJ; Crokaert F
    J Chemother; 1989 May; 1 Suppl 2():49-53. PubMed ID: 2681561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro antibacterial activity of piperacillin/quinolone combinations].
    Soussy CJ; Leclercq R; Duval J
    Pathol Biol (Paris); 1988 May; 36(5):357-60. PubMed ID: 3136421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced susceptibility of gram-negative bacteria to phagocytic killing by human polymorphonuclear leucocytes after brief exposure to aztreonam.
    Pruul H; Lewis G; McDonald PJ
    J Antimicrob Chemother; 1988 Nov; 22(5):675-86. PubMed ID: 3209526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conditions required for the bactericidal activity of 4-quinolones against Serratia marcescens.
    Lewin CS; Smith JT
    J Med Microbiol; 1990 Jul; 32(3):211-4. PubMed ID: 2165168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Killing of gram-negative bacteria by ciprofloxacin within both healthy human neutrophils and neutrophils with inactivated O2-dependent bactericidal mechanisms.
    Cantón E; Peman J; Cabrera E; Velert M; Orero A; Pastor A; Gobernado M
    Chemotherapy; 1999; 45(4):268-76. PubMed ID: 10394010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergy of imipenem--a novel carbapenem, and rifampin and ciprofloxacin against Pseudomonas aeruginosa, Serratia marcescens and Enterobacter species.
    Chin NX; Neu HC
    Chemotherapy; 1987; 33(3):183-8. PubMed ID: 3109815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro antibacterial activity and beta-lactamase stability of meropenem].
    Poiată A; Tuchiluş C; Bădicuţ I; Buiuc D
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):589-94. PubMed ID: 14756067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro evaluation of alaphosphin (Ro 03-7008) against Serratia marcescens.
    Traub WH
    Chemotherapy; 1980; 26(2):103-10. PubMed ID: 6988181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial activity of ofloxacin and its mode of action.
    Sato K; Inoue Y; Fujii T; Aoyama H; Mitsuhashi S
    Infection; 1986; 14 Suppl 4():S226-30. PubMed ID: 3028966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Susceptibility of clinical isolates to aztreonam].
    Nagasawa Z; Nishimura T; Nagumo F; Ueda H; Tadano J; Katoh O; Yamada H
    Jpn J Antibiot; 1989 Jun; 42(6):1257-70. PubMed ID: 2507799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.